IMMUNOBRAIN CHECKPOINT
ImmunoBrain Checkpoint is a biopharmaceutical company focused on developing a pipeline of novel disease-modifying immunotherapies for neurological disorders by targeting immune checkpoint pathways. IBC’s novel approach for treatment of neurodegeneration is based on years of innovative, cutting edge scientific discoveries made by Prof. Michal Schwartz (Weizmann Institute of Science, Israel).
IMMUNOBRAIN CHECKPOINT
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.ibcheckpoint.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.5 M USD
Technology used in webpage:
Google Apps For Business Microsoft Azure DNS GoDaddy DNS Google Google Cloud Google Cloud Oregon
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - ImmunoBrain Checkpoint
Alzheimer's Association
Alzheimer's Association investment in Grant - ImmunoBrain Checkpoint
The ALS Association
The ALS Association investment in Grant - ImmunoBrain Checkpoint
Official Site Inspections
http://www.ibcheckpoint.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 76.223.67.189
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
